Female cancer survivors are low responders and have reduced success compared with other patients undergoing assisted reproductive technologies

Fertility and Sterility

Volumn 97, Issue 2, 2012, Pages 381-386

  Barton, Sara E ^a   Missmer, Stacey A ^a,b   Berry, Katharine F ^a   Ginsburg, Elizabeth S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

assisted reproduction; Cancer; fertility preservation; IVF; poor responder; survivorship

Indexed keywords

ADULT; ARTICLE; BIRTH RATE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OOCYTE RETRIEVAL; PREGNANCY OUTCOME; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; BOSTON; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; LOGISTIC MODELS; MALE; NEOPLASMS; ODDS RATIO; OOCYTE RETRIEVAL; PREGNANCY; PREGNANCY RATE; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPERM INJECTIONS, INTRACYTOPLASMIC; SURVIVORS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84856381009     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.11.028     Document Type: Article

References (30)

1. American Cancer Society Cancer facts & figures, 2010 2010 American Cancer Society Atlanta
2. M.M. Geenen, M.C. Cardous-Ubbink, L.C. Kremer, C. van den Bos, H.J. van der Pal, and R.C. Heinen Medical assessment of adverse health outcomes in long-term survivors of childhood cancer JAMA 297 2007 2705 2715 (Pubitemid 47001096)
3. L.M. Madanat, N. Malila, T. Dyba, T. Hakulinen, R. Sankila, and J.D. Boice Jr. Probability of parenthood after early onset cancer: a population-based study Int J Cancer 123 2008 2891 2898
4. H. Magelssen, K.K. Melve, R. Skjaerven, and S.D. Fossa Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood Hum Reprod 23 2008 178 186 (Pubitemid 351767332)
5. D.M. Green, T. Kawashima, M. Stovall, W. Leisenring, C.A. Sklar, and A.C. Mertens Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study J Clin Oncol 27 2009 2677 2685
6. C.A. Sklar, A.C. Mertens, P. Mitby, J. Whitton, M. Stovall, and C. Kasper Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study J Natl Cancer Inst 98 2006 890 896 (Pubitemid 44018918)
7. L.E. Bath, W.H. Wallace, M.P. Shaw, C. Fitzpatrick, and R.A. Anderson Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-mullerian hormone, inhibin B and ovarian ultrasound Hum Reprod 18 2003 2368 2374 (Pubitemid 37427819)
8. E.C. Larsen, J. Muller, K. Schmiegelow, C. Rechnitzer, and A.N. Andersen Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer J Clin Endocrinol Metab 88 2003 5307 5314 (Pubitemid 37452732)
9. E.S. Ginsburg, E.H. Yanushpolsky, and K.V. Jackson In vitro fertilization for cancer patients and survivors Fertil Steril 75 2001 705 710 (Pubitemid 32273507)
10. I.S. Tummon, S.A. Daniel, B.R. Kaplan, J.A. Nisker, and A.A. Yuzpe Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization Fertil Steril 58 1992 563 568
11. L.P. Cheung, P.M. Lam, I.H. Lok, T.T. Chiu, S.Y. Yeung, and C.C. Tjer GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial Hum Reprod 20 2005 616 621 (Pubitemid 40425485)
12. W. Schoolcraft, T. Schlenker, M. Gee, J. Stevens, and L. Wagley Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol Fertil Steril 67 1997 93 97 (Pubitemid 26428419)
13. K.G. Dragisic, O.K. Davis, S.J. Fasouliotis, and Z. Rosenwaks Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders Fertil Steril 84 2005 1023 1026 (Pubitemid 41414601)
14. E.S. Surrey, J. Bower, D.M. Hill, J. Ramsey, and M.W. Surrey Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization Fertil Steril 69 1998 419 424
15. S. Greenland Modeling and variable selection in epidemiologic analysis Am J Public Health 79 1989 340 349 (Pubitemid 19077878)
16. J.A. Petrek, M.J. Naughton, L.D. Case, E.D. Paskett, E.Z. Naftalis, and S.E. Singletary Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study J Clin Oncol 24 2006 1045 1051 (Pubitemid 46638800)
17. E. Brusamolino, F. Lunghi, E. Orlandi, C. Astori, F. Passamonti, and C. Barate Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity Haematologica 85 2000 1032 1039
18. D. Meirow, and D. Nugent The effects of radiotherapy and chemotherapy on female reproduction Hum Reprod Update 7 2001 535 543 (Pubitemid 33069611)
19. C. Teinturier, O. Hartmann, D. Valteau-Couanet, E. Benhamou, and P.F. Bougneres Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure Bone Marrow Transplant 22 1998 989 994 (Pubitemid 28543061)
20. J.E. Sanders, J. Hawley, W. Levy, T. Gooley, C.D. Buckner, and H.J. Deeg Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation Blood 87 1996 3045 3052
21. E. Thibaud, K. Rodriguez-Macias, C. Trivin, H. Esperou, J. Michon, and R. Brauner Ovarian function after bone marrow transplantation during childhood Bone Marrow Transplant 21 1998 287 290 (Pubitemid 28052232)
22. R.A. Anderson, A.P. Themmen, A. Al-Qahtani, N.P. Groome, and D.A. Cameron The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer Hum Reprod 21 2006 2583 2592 (Pubitemid 44542149)
23. D. Meirow, M. Epstein, H. Lewis, D. Nugent, and R.G. Gosden Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations Hum Reprod 16 2001 632 637 (Pubitemid 32293787)
24. D.M. Green, C.A. Sklar, J.D. Boice Jr., J.J. Mulvihill, J.A. Whitton, and M. Stovall Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study J Clin Oncol 27 2009 2374 2381
25. S.J. Lee, L.R. Schover, A.H. Partridge, P. Patrizio, W.H. Wallace, and K. Hagerty American Society of Clinical Oncology recommendations on fertility preservation in cancer patients J Clin Oncol 24 2006 2917 2931 (Pubitemid 46655598)
26. L. Del Mastro, L. Boni, A. Michelotti, T. Gamucci, N. Olmeo, and S. Gori Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer JAMA 306 2011 269 276
27. S. Loibl, and B. Gerber Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer JAMA 306 2011 1760 author reply -1
28. B. Gerber, G. von Minckwitz, H. Stehle, T. Reimer, R. Felberbaum, and N. Maass Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study J Clin Oncol 29 2011 2334 2341
29. M.E. Clowse, M.A. Behera, C.K. Anders, S. Copland, C.J. Coffman, and P.C. Leppert Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis J Womens Health (Larchmt) 18 2009 311 319
30. Early Breast Cancer Trialists' Collaborative Group Ovarian ablation for early breast cancer Cochrane Database Syst Rev 2000 CD000485